Filing Summary
Company: Golden Sun Health Technology Group Limited
Filing: Form 6-K for the month of March 2024, filed March 21, 2024; Commission File No. 001-41425. The company is a Cayman Islands exempted company and identifies itself as a foreign private issuer filing annual reports on Form 20-F.
Business Context and Reporting Period
This filing relates to the company’s 2024 Extraordinary General Meeting of Shareholders. It furnishes meeting materials to shareholders, rather than reporting quarterly or annual operating results.
Financial and Operating Information
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, operating performance, or other financial metrics.
Material Changes Versus Prior Period
No financial or operational changes versus a prior comparable period are disclosed.
Meeting Materials, Outlook, and Risks
- Exhibit 99.1: Notice and Proxy Statement for the 2024 Extraordinary General Meeting, dated March 21, 2024.
- Exhibit 99.2: Form of Proxy Card for use at the meeting.
The filing text does not state the meeting date, agenda or proposed resolutions, voting recommendations, management guidance, business outlook, material risks, contingencies, or unusual items. These matters may be described in the furnished proxy materials, which are not included in the provided text.
Investor Verification Items
- Review Exhibit 99.1 for the meeting date, agenda, proposed resolutions, and any transaction or governance matters requiring shareholder approval.
- Review the proxy card and voting instructions in Exhibit 99.2.
- Confirm whether the company name referenced in related materials is “Golden Sun Health Technology Group Limited”; the supplied request metadata uses “Golden Sun Technology Group Ltd.”
- Obtain the company’s latest Form 20-F or other financial filing for current financial results, liquidity, debt, and risk disclosures.